CytomX Therapeutics
A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.
Key facts
| CAGE Code | 6Y2S4 |
|---|---|
| Legal Name | CytomX Therapeutics, Inc. |
| Company Operating Status | Active |
| Full Address | 151 Oyster Point Blvd, Suite 400 South San Francisco, CA 94080-1913, USA |
| Stock Symbol | CTMX |
| Ticker Symbol | CTMX |
| Wellfound ID | cytomx-therapeutics |
Contact details
Email and phone for CytomX Therapeutics are available to signed-in members of CliffBio.
Sign in to view